Connect with us

Hi, what are you looking for?

Editor's Pick

A Red Bar on the Homebuilders ETF

Homebuilders have been on an unbelievably big run. Looking at two relevant ETFs, we can see that one is at prior highs, while the other broke out to fresh new highs. Let’s start there.

XHB was recently at a prior high, and the ITB made newer highs. Amazingly, XHB — the homebuilders ETF — got within 0.01 cent of the prior high, then pulled back below the 10-week moving average on Thursday. Everything is still in an uptrend! The only real sign of weakness is the potential for a sell signal on the PPO.

  1. The SCTR is still at 97.0, which is very strong.
  2. Relative strength compared to the $SPX is in purple, and is still near the highs. If it started to break the trend line from early April, that would be another signal of weakness.
  3. Price stalled at the prior high.
  4. Volume has been strong. This is after Thursday’s move, and Friday’s volume will be an Options Expiration, so it could have a big volume bar to finish the week.
  5. Full stochastic shows price still trading in the top of the range for the last 3 months of the year, so no real new news there.
  6. PPO is trying to hold on the uptrend, but will be very close to a sell signal.

That’s a pretty strong basket of signals.

ITB, the home construction ETF, looks a little different this week. Namely, this is the first red week on the price panel since the lows of last October! Price is still holding on the trend line, but the red bar is a warning.

All of the other trends recorded on the chart above are intact, with one exception: the PPO is already on a sell signal.

The real question to ask for me is whether or not this is the end of this big trend. I don’t know if it is or not, but all the trends are being tested. It’s a good time to be careful, in case it starts to break down.

You May Also Like

Editor's Pick

Marc Joffe Federal, state, and local governments are being called upon to support struggling transit agencies to meet climate change goals. But spending money...

Editor's Pick

Walter Olson You sometimes hear people talk as if even plaintiffs with meritorious cases can’t win libel suits in American courts because of the...

Editor's Pick

David Boaz A new study by the Indian newspaper The Print, based on data from The Economist Intelligence Unit’s Democracy Index 2022, finds that...

Editor's Pick

Jeffrey A. Singer Earlier this week, the Food and Drug Administration issued a draft of proposed guidelines for clinical researchers conducting trials on psychedelic drugs....